| |
| |
|
| Insider
Information: |
Giacobello Scott M. |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,000 |
|
|
| Total
Value |
$35,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 63.8%
|
21.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gw Pharmaceuticals Plc |
GWPH |
Chief Financial Officer |
2021-05-05 |
0 |
2019-02-26 |
0 |
Premium* |
|
|
Aadi Bioscience, Inc |
AADI |
Chief Financial Officer |
2022-09-26 |
20,000 |
2022-09-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AADI |
Aadi Bioscience, Inc |
Chief Financial Officer |
• – – |
2022-09-26 |
4 |
A |
$12.50 |
$250,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2021-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(165,108) |
0 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
D |
$17.85 |
$58,905 |
D/D |
(3,300) |
165,108 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$9 |
D/D |
6,288 |
168,408 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2021-02-26 |
4 |
D |
$17.90 |
$1,397,918 |
D/D |
(78,096) |
161,120 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$209 |
D/D |
149,160 |
167,567 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2020-05-18 |
4 |
D |
$9.67 |
$559,081 |
D/D |
(57,816) |
91,062 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2020-05-18 |
4 |
OE |
$0.00 |
$140 |
D/D |
116,604 |
95,094 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2020-03-13 |
4 |
B |
$6.80 |
$48,960 |
D/D |
7,200 |
88,224 |
2.74 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
S |
$8.34 |
$18,515 |
D/D |
(2,220) |
81,024 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2020-02-26 |
4 |
S |
$9.17 |
$35,323 |
D/D |
(3,852) |
83,244 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2019-05-20 |
4 |
S |
$14.52 |
$61,332 |
D/D |
(4,224) |
87,096 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2019-05-18 |
4 |
OE |
$0.00 |
$11 |
D/D |
8,136 |
91,320 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2019-02-26 |
4 |
S |
$12.38 |
$65,124 |
D/D |
(5,232) |
10,536 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Financial Officer |
• – – |
2019-02-26 |
4 |
OE |
$0.00 |
$14 |
D/D |
10,404 |
15,768 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
